Lutathera and ASTX727 in Neuroendocrine Tumours

NCT05178693 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: ASTX727
RADIATION: Lutathera

Sponsor

Imperial College London

Collaborators

[object Object]